[go: up one dir, main page]

NO20005954D0 - Treatment of infertility with cAMP-increasing compounds alone or in combination with at least one meiosis stimulant - Google Patents

Treatment of infertility with cAMP-increasing compounds alone or in combination with at least one meiosis stimulant

Info

Publication number
NO20005954D0
NO20005954D0 NO20005954A NO20005954A NO20005954D0 NO 20005954 D0 NO20005954 D0 NO 20005954D0 NO 20005954 A NO20005954 A NO 20005954A NO 20005954 A NO20005954 A NO 20005954A NO 20005954 D0 NO20005954 D0 NO 20005954D0
Authority
NO
Norway
Prior art keywords
meiosis
infertility
stimulant
camp
treatment
Prior art date
Application number
NO20005954A
Other languages
Norwegian (no)
Other versions
NO20005954L (en
Inventor
Christa Hegele-Hartung
Quoc-Lam Cam
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO20005954L publication Critical patent/NO20005954L/en
Publication of NO20005954D0 publication Critical patent/NO20005954D0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20005954A 1998-05-26 2000-11-24 Treatment of infertility with cAMP-increasing compounds alone or in combination with at least one meiosis stimulant NO20005954D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98250177 1998-05-26
PCT/EP1999/003138 WO1999061010A2 (en) 1998-05-26 1999-05-07 Treatment of infertility with cam-increasing compounds alone or in combination with at least one meiosis-stimulating compound

Publications (2)

Publication Number Publication Date
NO20005954L NO20005954L (en) 2000-11-24
NO20005954D0 true NO20005954D0 (en) 2000-11-24

Family

ID=8234594

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005954A NO20005954D0 (en) 1998-05-26 2000-11-24 Treatment of infertility with cAMP-increasing compounds alone or in combination with at least one meiosis stimulant

Country Status (7)

Country Link
EP (1) EP1098652A2 (en)
JP (1) JP2002516272A (en)
KR (1) KR20010043828A (en)
AU (1) AU5408999A (en)
CA (1) CA2333320A1 (en)
NO (1) NO20005954D0 (en)
WO (1) WO1999061010A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1216059B1 (en) 1999-09-16 2005-10-19 Novo Nordisk A/S Composition for ivf
DE60034057T2 (en) * 1999-11-25 2007-12-06 Novo Nordisk A/S TREATMENT OF HUMAN BARRENESS
US6544166B1 (en) 1999-11-25 2003-04-08 Groendahl Christian Treatment of human infertility
AU3376501A (en) * 2000-02-25 2001-09-03 Novo Nordisk A/S Improvement of implantation rate
MXPA02007818A (en) * 2000-02-25 2002-10-23 Schering Ag Improvement of implantation rate.
EP1272618A2 (en) * 2000-04-06 2003-01-08 Novo Nordisk A/S Synchronization of the cytoplasmatic and nuclear maturation of oocytes in vitro
EP1147774A1 (en) * 2000-04-20 2001-10-24 Stichting Dienst Landbouwkundig Onderzoek Method for improving the quality of sperm for artificial insemination of animals
JP2003533222A (en) * 2000-05-18 2003-11-11 シエーリング アクチエンゲゼルシャフト Fertilization of aging oocytes
EP1245572A1 (en) 2001-03-26 2002-10-02 Schering Aktiengesellschaft Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation
CA2469939C (en) 2001-12-14 2012-06-19 Applied Research Systems Ars Holding N.V. Method of inducing ovulation using a non-polypeptide camp level modulator
WO2003070766A2 (en) * 2002-02-22 2003-08-28 Novo Nordisk A/S A transducer of mas signalling
WO2013030302A1 (en) 2011-08-30 2013-03-07 Centre National De La Recherche Scientifique Protein complex comprising mcm8 and mcm9 proteins and their use
GB201117453D0 (en) * 2011-10-10 2011-11-23 Univ Dundee Improved sperm function/activity
CN108531447B (en) * 2018-04-13 2021-11-23 上海市生物医药技术研究院 Compound for regulating sperm motility and assisted reproduction and application thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0196530A3 (en) * 1985-03-26 1989-03-22 CTA Finanz AG Agent and process for increasing growth, for optimizing fertility and for stimulating the immune system in humans and animals
US5716777A (en) * 1994-06-23 1998-02-10 Novo Nordisk A/S Regulation of meiosis using sterols
WO1996027658A1 (en) * 1995-03-06 1996-09-12 Novo Nordisk A/S Stimulation of meiosis
US5800625A (en) * 1996-07-26 1998-09-01 Cauldron Limited Partnership Removal of material by radiation applied at an oblique angle
CA2199663C (en) * 1997-03-11 2004-08-10 Ruth Miriam Moses In vitro maturation and fertilization of mammalian oocytes

Also Published As

Publication number Publication date
KR20010043828A (en) 2001-05-25
AU5408999A (en) 1999-12-13
WO1999061010A3 (en) 2000-04-27
NO20005954L (en) 2000-11-24
EP1098652A2 (en) 2001-05-16
CA2333320A1 (en) 1999-12-02
JP2002516272A (en) 2002-06-04
WO1999061010A2 (en) 1999-12-02

Similar Documents

Publication Publication Date Title
NO20005954D0 (en) Treatment of infertility with cAMP-increasing compounds alone or in combination with at least one meiosis stimulant
DK0927309T3 (en) Self-tapping screw
ID28949A (en) ABSORPTION ARTICLES THAT MAINTAIN OR IMPROVE SKIN HEALTH
DK0792144T3 (en) Cleaning tissues treated with water-in-lipid emulsion
IS1995B (en) Triazole derivatives, useful in treatment
ID26130A (en) IMPROVEMENTS IN MEDICAL INTRODUCTION TOOLS
BR9204375A (en) COMPOSITION AND PROCESS FOR THE REFRIGERATION WATER TREATMENT
DE69700671D1 (en) Lock nut
FI965144L (en) Sterol derivatives for use in the regulation of meiosis
PT1235831E (en) NEW OXABISPIDINE COMPOUNDS IN THE TREATMENT OF CARDIAC ARRHYTHMIAS
DK0948719T3 (en) Fastening screw with self-plowing threads
DE69903301D1 (en) WINDOWS OF HIGH SPUMBLE AND CORROSION RESISTANCE FOR PLASMA TREATMENT CHAMBERS
PT1015467E (en) ERITROMYCIN DERIVATIVES IN BRIDGE 6,9-
NO970631D0 (en) Methods for Treating Sepsis or Inflammatory Diseases with Oxypurine Nucleosides
BR9612283A (en) Composition for the treatment of stains on garments and treatment methods
DE69805242D1 (en) titanium aluminide
PT1211946E (en) FRESH MEAT TREATMENT PROCESS
ATA59298A (en) WINDOW OR DOOR
ATA102298A (en) WINDOW OR DOOR
IT237536Y1 (en) SECTIONAL DOOR PERFECTED
BR9708146A (en) Treatment process for common cold or allergic rhinitis
NO20010354L (en) Substituted phenylamidines with antithrombotic effect
ID28335A (en) PANIC ATTACK TREATMENT
ES1044515Y (en) PANTS FOR THE TOPICAL TREATMENT OF CELLULITE
KR960017879U (en) Combination structure of door frame

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application